Academic Bibliography

Search 200 years of publications by Ghent University researchers.

Jan Vanwelkenhuyzen

Faculty of Medicine and Health Sciences > Department of Human Structure and Repair

ORCID iD: 0000-0001-6180-1889

Add to list
- PhD Thesis
From mutations to splice variants : identifying liquid biopsy derived biomarkers in metastatic prostate cancer

Jan Vanwelkenhuyzen (UGent)

(2024)
Add to list
- Journal Article
- A1
- open access
AR and PI3K genomic profiling of cell-free DNA can identify poor responders to Lutetium-177-PSMA among patients with metastatic castration-resistant prostate cancer

Jan Vanwelkenhuyzen (UGent) , Eva Van Bos, Siska Van Bruwaene, Karl Lesage, Alex Maes, Sezgin Üstmert, Filip Lavent, Laurence Beels, Henrik Grönberg, Piet Ost (UGent) , et al.

(2023) EUROPEAN UROLOGY OPEN SCIENCE. 53. p.63-66
Add to list
- Conference Paper
- C3
Towards the discovery of prognostic and predictive biomarkers in CHEERS, a radioimmunotherapy phase II trial

Jan Vanwelkenhuyzen (UGent) , Mathieu Spaas (UGent) , Kim Van der Eecken, Vibeke Kruse (UGent) , Sylvie Rottey (UGent) , Lieve Brochez (UGent) , Johan Lindberg, Katleen De Preter (UGent) , Bram De Laere (UGent) and Piet Ost (UGent)

(2022) OncoPoint Symposium, 8th, Abstracts.
Add to list
- Conference Paper
- C3
Toward methodology for comprehensive androgen receptor splice variant profiling in cell-free RNA from patients with metastatic prostate cancer

Jan Vanwelkenhuyzen (UGent) , Pieter-Jan van Dam, Katleen De Preter (UGent) , Johan Lindberg, Piet Ost (UGent) and Bram De Laere (UGent)

(2022) Belgian Association for Cancer Research, 2022 Annual meeting, Abstracts.
Add to list
- Conference Paper
- C3
Development of an androgen receptor (AR) splice variant targeting, cell-free RNA and treatment-predictive biomarker assay for men with metastatic castration-resistant prostate cancer (mCRPC)

Jan Vanwelkenhuyzen (UGent)

(2022) 9th Belgian Multidisciplinary Meeting on Urological Cancers, Abstracts.
Add to list
Tissue- and blood-derived genomic biomarkers for metastatic hormone-sensitive prostate cancer : a systematic review

Kim Van der Eecken, Jan Vanwelkenhuyzen (UGent) , Matthew P. Deek, Phuoc T. Tran, Evan Warner, Alexander W. Wyatt, Edmond M. Kwan, Sofie Verbeke (UGent) , Jo Van Dorpe (UGent) , Valerie Fonteyne (UGent) , et al.

(2021) EUROPEAN UROLOGY ONCOLOGY. 4(6). p.914-923
Add to list
- Conference Paper
- C3
- open access
Multifocality in prostate cancer : implications for PAM50 subtyping using an index lesion-only approach

Kim Van der Eecken, Maarten Larmuseau (UGent) , Jan Vanwelkenhuyzen (UGent) , Nicolaas Lumen (UGent) , Kathleen Marchal (UGent) , Jo Van Dorpe (UGent) , Piet Ost (UGent) , Bram De Laere (UGent) and Sofie Verbeke (UGent)

(2021) Global Congress on Prostate and Bladder Cancer 2021, Abstracts.
Add to list
- Conference Paper
- C3
Inferring the genomic landscape of lymph-node positive high-risk prostate cancer

Jan Vanwelkenhuyzen (UGent) , Kim Van der Eecken, Bram De Laere (UGent) , Simon Sundling, Rebecka Bergström, Johan Lindberg, Katleen De Preter (UGent) , Henrik Grönberg and Piet Ost (UGent)

(2020) 7th edition of the annual BMUC meeting, Abstracts.
Add to list
- Conference Paper
- C3
Tracking the origins of metastatic seeding in de novo metastatic prostate cancer

Kim Van der Eecken, Evan Warner, Nicolaas Lumen (UGent) , Matti Annala, Andrew Murtha, Elena Schönlau, Nicolette Fonseca, Cameron Herberts, Jan Vanwelkenhuyzen (UGent) , Wesley Verla (UGent) , et al.

(2020) Belgian Society for Human Genetics, 20th Annual meeting, Abstracts.